8001-22-7

Basic information

• Product Name: SOYBEAN OIL
• Synonyms: Best One Soya;Bionatrol;CAP 18;CAP 18 (oil);CT 7000;Destiny HC;Fats and Glyceridic oils, soybean;HY 3050
• CAS NO: 8001-22-7
• Molecular Weight: 0
• EINECS: 232-274-4
• Mol File: 8001-22-7.mol
• Article Data: 0

Chemical Properties

• Flash Point: >230 °F
• Appearance: Colorless to Yellow/Oil
• Density: 0.917 g/mL at 25 °C(lit.)
• Refractive Index: n20/D 1.4743(lit.)
• Storage Temp.: 2-8°C
• Water Solubility: Miscible with absolute alcohol, ether, petroleum ether. Immiscible with water.
• CAS DataBase Reference: SOYBEAN OIL(CAS DataBase Reference)
• NIST Chemistry Reference: SOYBEAN OIL(8001-22-7)
• EPA Substance Registry System: SOYBEAN OIL(8001-22-7)

Safety Data

• RTECS: WG4862000
• F: 8
• TSCA: Yes
• Hazardous Substances Data: 8001-22-7(Hazardous Substances Data)

Usage

Description

Soybean oil, also known as soy oil, is a vegetable oil extracted from the seeds of the soybean plant. It is composed of approximately 86% unsaturated fatty acids, with linoleic and oleic acids being the primary components. Soybean oil is available in both hydrogenated and unhydrogenated forms and is widely used in various applications due to its versatile properties.

Uses

Used in Food Industry:
Soybean oil is used as a cooking oil for its high smoke point and rich nutritional content. It is also used in the production of shortenings and margarine in its hydrogenated form, providing stability and a desirable texture.
Used in Pharmaceutical Industry:
Soybean oil serves as a pharamaceutic necessity, utilized in the formulation of various medications and supplements due to its beneficial fatty acid profile and ability to enhance absorption.
Used in Cosmetics Industry:
Soybean oil is used as an ingredient in cosmetics and personal care products, such as lotions and creams, due to its moisturizing and emollient properties.
However, its use in salad and cooking oils in the unhydrogenated form is limited by its tendency to develop undesirable odors and flavors when exposed to air or heated to frying temperatures.

Production Methods

Obtained by solvent extraction using petroleum hydrocarbons, or to a lesser extent by expression using continuous screw-press operations, of the seeds of either Glycine max (Leguminosae) or Glycine soja (Leguminosae). The oil is refined, deodorized, and clarified by filtration at about 0℃. Any phospholipids or sterols present are removed by refining with alkali.

Air & Water Reactions

Insoluble in water.

Reactivity Profile

SOYBEAN OIL react with acids to liberate heat. Heat is also generated by interaction with caustic solutions. Strong oxidizing acids may cause a vigorous reaction that is sufficiently exothermic to ignite the reaction products. Flammable hydrogen is generated by mixing with alkali metals and hydrides. React slowly with oxygen in the air to become rancid.

Health Hazard

None-is a food.

Pharmaceutical Applications

In pharmaceutical preparations, soybean oil emulsions are primarily used as a fat source in total parenteral nutrition (TPN) regimens. Although other oils, such as peanut oil, have been used for this purpose, soybean oil is now preferred because it is associated with fewer adverse reactions. Emulsions containing soybean oil have also been used as vehicles for the oral and intravenous administration of drugs; drug substances that have been incorporated into such emulsions include amphotericin, diazepam, retinoids, vitamins, poorly water-soluble steroids, fluorocarbons, ibuprofen, and insulin. In addition, soybean oil has been used in the formulation of many drug delivery systems such as liposomes, microspheres, dry emulsions, self-emulsifying systems, microemulsions,nanoemulsions and nanocapsules, solid-in-oil suspensions, and multiple emulsions. Soybean oil may also be used in cosmetics and is consumed as an edible oil. As soybean oil has emollient properties, it is used as a bath additive in the treatment of dry skin conditions.

Safety

Soybean oil is widely used intramuscularly as a drug vehicle or as a component of emulsions used in parenteral nutrition regimens; it is also consumed as an edible oil. Generally, soybean oil is regarded as an essentially nontoxic and nonirritant material. However, serious adverse reactions to soybean oil emulsions administered parenterally have been reported. These include cases of hypersensitivity, CNS reactions, and fat embolism. Interference with the anticoagulant effect of warfarin has also been reported. Anaphylactic reactions have also been reported following the consumption of foods derived from, or containing, soybeans. Recently there has been concern at the concentration of phytoestrogens in some soy-derived products. Administration of soy protein to humans has resulted in significantly decreased serum lipid concentrations. In 1999, the UK Medical Devices Agency announced the voluntary withdrawal of a breast implant that contained soybean oil. The decision was taken because not enough was known at that time about the long-term safety and the rate of breakdown of the soybean oil in the filling and its possible effects on the body. LD50 (mouse, IV): 22.1 g/kg LD50 (rat, IV): 16.5 g/kg

storage

Soybean oil is a stable material if protected from atmospheric oxygen. The formation of undesirable flavors in soybean oil is accelerated by the presence of 0.01 ppm copper and 0.1 ppm iron, which act as catalysts for oxidation; this can be minimized by the addition of chelating agents. Prolonged storage of soybean oil emulsions, particularly at elevated temperatures, can result in the formation of free fatty acids, with a consequent reduction in the pH of the emulsion; degradation is minimized at pH 6–7. However, soybean oil emulsions are stable at room temperature if stored under nitrogen in a light-resistant glass container. Plastic containers are permeable to oxygen and should not be used for long-term storage since oxidative degradation can occur. The stability of soybean oil emulsions is considerably influenced by other additives in a formulation. Soybean oil should be stored in a well-filled, airtight, lightresistant container at a temperature not exceeding 25℃.

Incompatibilities

Soybean oil emulsions have been reported to be incompatible at 25°C with a number of materials including calcium chloride, calcium gluconate, magnesium chloride, phenytoin sodium, and tetracycline hydrochloride. Lower concentrations of these materials, or lower storage temperatures, may result in improved compatibility. The source of the material may also affect compatibility; for example, while one injection from a particular manufacturer might be incompatible with a fat emulsion, an injection with the same amount of active drug substance from another manufacturer might be compatible. Amphotericin B has been reported to be incompatible with soybean oil containing fat emulsions under certain conditions. Soybean oil emulsions are also incompatible with many other drug substances, IV infusion solutions, and ions (above certain concentrations). When plastic syringes are used to store soybean oil emulsion, silicone oil may be extracted into the emulsion; swelling of the syringe pump also occurs, resulting in the necessity for increased forces to maintain the motion of the plunger.

Regulatory Status

Included in the FDA Inactive Ingredients Database (IV injections, oral capsules, and topical preparations). Included in nonparenteral (chewable tablets; oral capsules; oral lozenges; topical bath additives) and parenteral (emulsions for IV injection or infusion) medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.

Downstream Products

• 111-65-9 octane 
• 111-84-2 nonane 
• 124-18-5 decane 
• 1120-21-4 n-Undecane 
• 112-40-3 dodecane 
• 629-62-9 pentadecane 
• 142-82-5 n-heptane 
• 629-50-5 Tridecane 
• 629-59-4 tetradecane 
• 544-76-3 Hexadecane 
• 629-78-7 hepatdecane 
• 593-45-3 octadecane 
• 57-11-4 stearic acid 
• 693-61-8 (E)-2-undecene